256 related articles for article (PubMed ID: 9343406)
1. Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells.
Martínez-Martínez S; Gómez del Arco P; Armesilla AL; Aramburu J; Luo C; Rao A; Redondo JM
Mol Cell Biol; 1997 Nov; 17(11):6437-47. PubMed ID: 9343406
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways.
Sancho R; Macho A; de La Vega L; Calzado MA; Fiebich BL; Appendino G; Muñoz E
J Immunol; 2004 Feb; 172(4):2341-51. PubMed ID: 14764703
[TBL] [Abstract][Full Text] [Related]
3. Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells.
Aoki Y; Kao PN
Antimicrob Agents Chemother; 1999 Nov; 43(11):2678-84. PubMed ID: 10543746
[TBL] [Abstract][Full Text] [Related]
4. Divergent effects of dithiocarbamates on AP-1-containing and AP-1-less NFAT sites.
Saccani S; Saccani A; Varesio L; Ghosh P; Young HA; Sica A
Eur J Immunol; 1999 Apr; 29(4):1194-201. PubMed ID: 10229086
[TBL] [Abstract][Full Text] [Related]
5. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding.
Aramburu J; Azzoni L; Rao A; Perussia B
J Exp Med; 1995 Sep; 182(3):801-10. PubMed ID: 7650486
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of NFAT activation and T cell cytokine production by novel low molecular weight pyrazole compounds.
Trevillyan JM; Chiou XG; Chen YW; Ballaron SJ; Sheets MP; Smith ML; Wiedeman PE; Warrior U; Wilkins J; Gubbins EJ; Gagne GD; Fagerland J; Carter GW; Luly JR; Mollison KW; Djuric SW
J Biol Chem; 2001 Dec; 276(51):48118-26. PubMed ID: 11592964
[TBL] [Abstract][Full Text] [Related]
7. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors.
Márquez N; Sancho R; Macho A; Calzado MA; Fiebich BL; Muñoz E
J Pharmacol Exp Ther; 2004 Mar; 308(3):993-1001. PubMed ID: 14617683
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT.
Paliogianni F; Boumpas DT
Cell Immunol; 1996 Jul; 171(1):95-101. PubMed ID: 8660843
[TBL] [Abstract][Full Text] [Related]
9. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
Tsatsanis C; Patriotis C; Tsichlis PN
Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.
Gringhuis SI; de Leij LF; Verschuren EW; Borger P; Vellenga E
Blood; 1997 Oct; 90(7):2690-700. PubMed ID: 9326236
[TBL] [Abstract][Full Text] [Related]
11. Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1.
Fortin JF; Barbeau B; Robichaud GA; Paré ME; Lemieux AM; Tremblay MJ
Blood; 2001 Apr; 97(8):2390-400. PubMed ID: 11290602
[TBL] [Abstract][Full Text] [Related]
12. N-substituted benzamides inhibit nuclear factor-kappaB and nuclear factor of activated T cells activity while inducing activator protein 1 activity in T lymphocytes.
Lindgren H; Pero RW; Ivars F; Leanderson T
Mol Immunol; 2001 Aug; 38(4):267-77. PubMed ID: 11566320
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line.
Irvin BJ; Williams BL; Nilson AE; Maynor HO; Abraham RT
Mol Cell Biol; 2000 Dec; 20(24):9149-61. PubMed ID: 11094067
[TBL] [Abstract][Full Text] [Related]
14. JNK (c-Jun NH2-terminal kinase) is a target for antioxidants in T lymphocytes.
Gómez del Arco P; Martínez-Martínez S; Calvo V; Armesilla AL; Redondo JM
J Biol Chem; 1996 Oct; 271(42):26335-40. PubMed ID: 8824287
[TBL] [Abstract][Full Text] [Related]
15. Pseudoephedrine inhibits T-cell activation by targeting NF-κB, NFAT and AP-1 signaling pathways.
Fiebich BL; Collado JA; Stratz C; Valina C; Hochholzer W; Muñoz E; Bellido LM
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):98-106. PubMed ID: 21631396
[TBL] [Abstract][Full Text] [Related]
16. Repression of FasL expression by retinoic acid involves a novel mechanism of inhibition of transactivation function of the nuclear factors of activated T-cells.
Lee MO; Kang HJ; Kim YM; Oum JH; Park J
Eur J Biochem; 2002 Feb; 269(4):1162-70. PubMed ID: 11856352
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive effect of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through the inhibition of T-lymphocyte proliferation and IL-2 production.
Yun CH; Son CG; Jung U; Han SH
Toxicology; 2006 Jan; 217(1):31-8. PubMed ID: 16168555
[TBL] [Abstract][Full Text] [Related]
18. Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50.
Torgerson TR; Colosia AD; Donahue JP; Lin YZ; Hawiger J
J Immunol; 1998 Dec; 161(11):6084-92. PubMed ID: 9834092
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation.
Jimenez JL; Punzón C; Navarro J; Muñoz-Fernández MA; Fresno M
J Pharmacol Exp Ther; 2001 Nov; 299(2):753-9. PubMed ID: 11602691
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor.
Alroy I; Towers TL; Freedman LP
Mol Cell Biol; 1995 Oct; 15(10):5789-99. PubMed ID: 7565732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
